Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Evaluation of bacteriochlorophyll-reconstituted low-density lipoprotein nanoparticles for photodynamic therapy efficacy in vivo.

Marotta DE, Cao W, Wileyto EP, Li H, Corbin I, Rickter E, Glickson JD, Chance B, Zheng G, Busch TM.

Nanomedicine (Lond). 2011 Apr;6(3):475-87. doi: 10.2217/nnm.11.8.

2.

Motexafin lutetium-photodynamic therapy of prostate cancer: short- and long-term effects on prostate-specific antigen.

Patel H, Mick R, Finlay J, Zhu TC, Rickter E, Cengel KA, Malkowicz SB, Hahn SM, Busch TM.

Clin Cancer Res. 2008 Aug 1;14(15):4869-76. doi: 10.1158/1078-0432.CCR-08-0317.

3.

Effect of photosensitizer dose on fluence rate responses to photodynamic therapy.

Wang HW, Rickter E, Yuan M, Wileyto EP, Glatstein E, Yodh A, Busch TM.

Photochem Photobiol. 2007 Sep-Oct;83(5):1040-8.

PMID:
17880498
4.

Photofrin uptake in the tumor and normal tissues of patients receiving intraperitoneal photodynamic therapy.

Hahn SM, Putt ME, Metz J, Shin DB, Rickter E, Menon C, Smith D, Glatstein E, Fraker DL, Busch TM.

Clin Cancer Res. 2006 Sep 15;12(18):5464-70.

Supplemental Content

Loading ...
Support Center